Poster Abstracts • OFID 2018:5 (Suppl 1) • S631 time at 275°F followed by a 16 minute dry time. This process was initially intended for a single instrument (e.g., a one of a kind item that may have been dropped during the surgical procedure). Although efforts to minimize flash sterilization at our institution have been successful (we saw only 11 instances in February, 2018), immediate-use sterilization remains common in some operating rooms (OR).
Background. Surgical site infections in neurosurgery occur in up to 10% of procedures. The American Society of Health-System Pharmacists guidelines promote antimicrobial prophylaxis (AP) for up to 24 hours from neurosurgery using cefazolin while the Neurocritical Care Society guidelines promote single pre-procedural dose of AP for extraventricular drain (EVD) monitoring. Despite these guidelines, practice variation exists with often longer antimicrobial exposure and subsequent complications.
Methods. This retrospective study included patients admitted to Baylor University Medical Center from January 1, 2014 to September 20, 2017 and underwent cranial or spinal neurosurgery requiring AP. This study excluded patients with basilar skull fracture, presence of cerebrospinal fluid leak, penetrating trauma, meningitis, and patients receiving antibiotics for documented or suspected infection unrelated to neurosurgery. Patients who received AP for up to 24H (short course) were compared with patients who received AP for greater than 24H (long course) at 90 days. Data were analyzed using the Fisher exact test, Student's t-test and Wilcoxon rank-sum tests as applicable.
Results. A total of 183 patients were included with 90 and 93 patients receiving short or long courses of AP, respectively. Baseline characteristics were similar for the groups. Patients in the short course AP group received a mean antibiotic duration of 16.9 ± 4.3H while those in the long course AP group received 72.2 ± 50.9H (P < 0.001). The mean number of antimicrobials prescribed was 1.1 vs. 1.8 (P < 0.001) in the short vs. long groups, respectively. At 90 days, there were no significant differences in the rate of surgical site infections (1.1% vs. 2.1%, P = 0.99), development of multi-drug-resistant infections (2.2% vs. 2.2%, P = 0.99), and Clostridium difficile infection (0% vs. 1.1%, P = 0.99) in the short vs. long groups, respectively.
Conclusion. The rate of surgical site infections was not significantly different in patients that received short vs. long durations of antimicrobial prophylaxis. These results highlight an opportunity to improve antibiotic use and promote principles of antimicrobial stewardship in neurosurgery.
Disclosures. October 6, 2018: 12:30 PM Background. Changes in vital signs are frequently the first sign to point to pathology in the postoperative setting. There is no prediction model that exists that evaluates risk of postoperative complication in real-time. We are interested in understanding if we are able to risk stratify patients after surgery using novel predictors, trajectories of the various vital signs and evaluating their ability to risk stratify patients.
Methods. We reviewed patients who underwent pancreatectomy at an academic health system from January 2015 to February 2018. Postoperative complications were abstracted using definitions set by the National Surgical Quality Improvement Program (NSQIP) and vital signs, including pain score, were extracted from the Data Warehouse. Group-based trajectory modeling, a technique used to identify distinct clusters of patients with similar trajectories, was used to group patients with similar temperature, heart rate, blood pressure and pain scores. Postoperative complications were tabulated for each risk group and chi-square test was used to compare categorical variables.
Results. A total of 195 patients with pancreatectomy were evaluated and the rate of NSQIP complications was 35.4%. Pancreatectomy patients clustered into two distinct clusters for temperature, heart rate, systolic blood pressure and pain score. All four of these vital signs were able to stratify infectious and inflammatory complications between low-and high-risk groups but only systolic blood pressure was significant in stratifying readmission risk and heart rate and pain score for stratifying sepsis risk (Table 1) .
Conclusion. Trends of vital signs may be important predictors of complications. Some vital signs may be better at predicting distinct complications. More work is required to understand if different covariates within trajectory analysis can be combined to further enhance risk stratification for any and specific postoperative complications. Methods. Surveillance data based on NHSN/CDC protocols were collected between 2013 and 2017 from nine hospitals at Belo Horizonte, Brazil. Outcome: meningitis, hospital death and total length of hospital stay. Twenty-three independent variables were analyzed using Epi Info and applying statistical two-tailed test hypothesis with significance level of 5%.
Results. A sample of 4,549 patients submitted to craniotomy was analyzed: risk of meningitis = 1.9% (IC 95% = 1.6%; 2.4%). Mortality rate in patients without infection was 9% rising to 33% in infected patients (P < 0.01). Hospital length of stay in non-infected patients (days): mean = 18, median = 7, std. dev. = 36. Hospital stay in infected patients: mean = 56, median = 37, std. dev. = 63 (P < 0.001). The duration of procedure was the main risk factor for meningitis: 1.5% risk of meningitis in surgery less than or equal to 4 hours vs. 2.5% if the duration of procedure was more than 4 hours (relative risk = 1.7; P = 0.041). From 88 meningitis, in 68 (77%) the etiologic agent was identified: Klebsiella pneumoniae (20%), Staphylococcus aureus (16%), Acinetobacter baumannii (13%), Pseudomonas aeruginosa (9%), Staphylococcus sp. (8%), Acinetobacter sp. (7%), Staphylococcus epidermidis (5%), and other (20%).
Conclusion. The study showed how much meningitis is devastating, rising the death risk and length of hospital stay.
Disclosures. All authors: No reported disclosures. October 6, 2018: 12:30 PM Background. In countries with a high incidence of interpersonal violence involving firearms, gunshot wound (GSW) related infection is a regular and serious complication. However, limited evidence supports the efficacy of antimicrobial prophylaxis (AP) in resource restricted areas. At Tygerberg Hospital, South Africa, it is standard care for GSW patients to receive one dose of amoxicillin-clavulanic acid or cefazolin to prevent GSW-related infection. For various reasons protocol adherence can be suboptimal. This study aimed to assess the efficacy in regard to reduction of in-hospital GSW infection and to identify opportunities for practice improvement.
Efficacy and Patterns of Antimicrobial Prophylaxis for Gunshot Wound Infection in a South
Methods. All GSW patients admitted between October 12, 2017 and January 3, 2018 were prospectively included. Data regarding injury characteristics, circumstances of the incident, type of AP and surgery were obtained. The occurrence of in-hospital GSW infection was monitored over 30 days or until discharge, whichever occurred first. Univariate analyses were performed to compare characteristics of patients withand without prophylaxis. A multivariate logistic regression model was used to obtain propensity scores. To correct for confounding, propensity score matching (PSM) and inverse probability weighting (IPW) methods were used to assess the effect of AP on the occurrence of GSW infection.
Results. A total of 165 consecutive patients were included. Hundred-and-three patients received AP according to protocol within 12 hours after admission, 62 patients did not. Only 63.9% of the multi-GSW patients and 69.1% of the patients with a fracture received AP. These conditions were associated with an uncorrected relative risk for infection of 2.08 (95% CI 1.32-3.26) and 1.81 (95% CI 1.08-3.04), respectively. PSM showed a reduced in-hospital GSW infection risk of 12% (95% CI 0.2-24%, P = 0.046) with AP. IPW showed that AP reduced the risk for infection by 14% (95% CI, 3-27%, P = 0.015).
Conclusion. Providing antimicrobial prophylaxis to GSW patients appeared to result in a clinically relevant lower risk of in-hospital GSW infection. In this study setting, optimization of provision of AP for all patients with multiple GSW's or a GSWrelated fracture are opportunities for reduction of GSW infection.
Disclosures. October 6, 2018: 12:30 PM Background. Cluster randomized control trials (CRCTs) are used frequently in the field of infection control and antimicrobial stewardship because randomization at the patient level is often not feasible due to contamination, ethical, or logistical issues. The correlation and thus non-independence that exists among individual patients in a cluster must be accounted for when estimating sample size for such trials, yet many studies neglect to consider or report the intracluster correlation coefficient (ICC) and the resulting coefficient of variation (CV) in rates between hospitals. The aim of this study was to estimate the sample sizes needed to adequately power studies of hospital-level interventions to reduce rates of healthcare-associated infections.
Methods. We calculated the minimum number of clusters or hospitals that would need to be included in a study to have good power to detect an impact of the intervention given a range of different assumptions. We estimated parameters needed for these calculations using national rates from the National Healthcare Safety Network (NHSN) for methicillin-resistant Staphylococcus aureus (MRSA) bacteremia, central-line associated bloodstream infections (CLABSI), catheter-associated urinary tract infections (CAUTI), C. difficile infections (CDI) and variation between hospitals in these rates. These calculations were based on the assumption that hospitals were uniform and moderate in size and were studied for 1 year.
Results. To study an intervention leading to a 50% decrease in daily rates and using the C vs. calculated from NHSN, 22 average-sized hospitals for MRSA bacteremia are needed, 34 for CAUTI, 9 for CDI, and 27 for CLABSI to have a statistically significant decrease with a type I error rate of 0.05 and a type II error rate of 0.8. If a 10% decrease in rates is expected instead, 709, 1205, 279, and 866 hospitals, respectively, are needed.
Conclusion. Sample size estimates for CRCTs are most influenced by the CV and the expected effect size. Given the large sample size requirements, it is likely that many CRCTs in hospital epidemiology are under-powered. We hope that these findings lead to more definitive CRCTs in the field of hospital epidemiology that are properly powered and more studies reporting their ICC or CV.
Disclosures. 
